SUMMARY
Leukocyte telomere shortening reflects stress burdens and has been associated with cardiac events. However, the patient-specific clinical value of telomere assessment remains unknown. Moreover, telomere shortening cannot be inferred from a single telomere length assessment. The authors investigated and developed a novel strategy for gauging leukocyte telomere shortening using autologous cardiac atrial referencing. Using multitissue assessments from 163 patients who underwent cardiovascular surgery, we determined that the cardiac atrium-leukocyte telomere length difference predicted post-operative complexity. This constituted the first evidence that a single-time assessment of telomere dynamics might be salient to acute cardiac Leukocyte TL is measured from a single blood sample and has received particular attention in human studies. Several large cross-sectional studies have revealed that adults with short leukocyte telomeres are at increased risk of aging-associated diseases, including coronary artery disease (1-4), heart failure (5), and stroke (2) (3) (4) . However, despite these associations, the value of knowing an individual's leukocyte TL is unclear, and whether telomere assessment is useful for clinical decision-making is uncertain (6, 7) .
Leukocyte telomere shortening is an alternative telomere assessment that, in theory, might provide meaningful information for patient care. Leukocyte telomeres shorten in response to replicative and oxidative stresses, and the extent of shortening has been considered to serve as an aggregate indicator of these biological stresses (8) (9) (10) . Although less studied in humans than leukocyte TL, leukocyte telomere shortening has also been associated with cardiovascular outcomes (11, 12) . However, leukocyte telomere shortening cannot be inferred from a single leukocyte TL measurement. This is because the major determinant of leukocyte TL is inheritance, which accounts for up to 80% of the TL variation in the population (13) (14) (15) . In addition, serially measuring TL to ascertain the shortening rate has limited value in the clinical setting. The relatively low leukocyte telomere attrition rate (w20 to 40 base pairs [bps] per year) (2, 13, 16, 17) means that typically 5 to 10 years of follow-up are required to discriminate a change in TL (12, 18) .
Recently, an alternative approach to assessing leukocyte telomere attrition was proposed based on referencing leukocyte TL to that of a nonreplicating tissue in the same individual (19) . A quasilongitudinal assessment of telomere shortening might thus be made. In the dog, skeletal muscle TL was found to be stable over time, and the difference in TL between skeletal muscle and leukocytes correlated with age better than leukocyte TL alone did (19) . Comparing leukocyte and skeletal muscle TL has been termed the "blood-and-muscle model" and has yielded insights into human telomere length dynamics (15, 20, 21) .
Although conceptually interesting, whether an internal TL referencing approach has the power to inform clinical decision-making is unknown. At a more fundamental level, it is also unclear what the most suitable reference tissue for this purpose might be. Ideally, this would be tissue in which the TL is stable over the course of adulthood. However, there are limited human data on telomere dynamics in tissues other than leukocytes. In addition, although some reports have suggested that human skeletal muscle TL is invariant over time (22, 23) , recent larger studies have indicated that skeletal muscle telomeres shorten in adults (20, 21) . Yin et al.
The purpose of this study was to determine if there was a muscle-based strategy for gauging leukocyte TL shortening that was biologically rational and clinically meaningful for individuals with advanced cardiovascular disease. We studied 163 patients who underwent cardiac surgery and measured TL in their leukocytes, skeletal muscle, and cardiac right atrium.
We found that, although there was evidence for telomere shortening in adult skeletal muscle, shortening was not evident for telomeres in the right atrium during 6 decades of life. Furthermore, a wide intraindividual difference between right atrium TL and leukocyte TL was associated with a more to absolute length (kilobase pair) was undertaken using DNA oligomer standards for both telomere repeats and 36B4, as described previously (26) . 
Atrial-Leukocyte Telomere Dynamics were included as an aggregate endpoint (29). The length of stay in the intensive care unit (ICU) was recorded in days.
STATISTICAL ANALYSIS. The target sample size for this study was based on a post-operative event rate of 15% (29,31) and an assumption that the effect size for telomere shortening on post-operative events would be similar to that of leukocyte TL on mortality (32, 33) .
This yielded a sample size of 119 to detect an odds ratio (OR) of 1. (22) 31 (24) 5 (15) Comorbidities other than diabetes 68 (42) 56 (43) 12 (36) Recent (30 days) myocardial infarction 8 (5) 7 (6) 1 (3) Cerebrovascular disease 16 (10) 14 (11) 2 (6) Congestive heart failure 14 (9) 12 (9) 2 (6) Peripheral vascular disease 26 (16) 22 (17) 4 (12) Chronic obstructive pulmonary disease 23 (14) 20 (15) 3 (9) Renal failure requiring dialysis 3 (2) 2 (2) 1 (3) Re-operation 4 (2) 3 (2) 1 (3) Operative features
Surgical procedure CABG 68 (42) 57 (44) 11 (33) Valve 25 (15) 17 (13) (17) 21 (16) 7 (21) Values are n, mean AE SD (range), or n (%).
BMI ¼ body mass index; CABG ¼ coronary artery bypass grafting. In contrast to skeletal muscle, we did not find evidence for age-associated telomere shortening in the cardiac atrium. The explanation for this difference was speculative but might reflect lower progenitor cell activity in adult atria. Recent carbon-14 dating studies showed that cardiomyocyte turnover was substantially less than that of skeletal muscle cells (35, 36) . It was also possible that emergence of noncardiomyocyte cells with inherently longer telomeres could counterbalance telomere shortening from cell turnover. In this regard, it is noteworthy that 26% of subjects had a history of atrial fibrillation, a condition associated with atrial fibrosis. Although the TL of atrial fibroblasts versus cardiomyocytes is unknown, fibroblast-like cells in liver were found to have longer telomeres than parenchymal cells (37) . As well, a recent study of patients with atrial Plots showing a relationship between (A) leukocyte TL and age and (B) skeletal muscle TL and age, (C) but not the right atrium TL and age. Abbreviation as in Figure 1 .
fibrillation did not find an association between atrial TL and age (38) . Regardless of the exact atrial dynamics, our findings empirically established that the net effect of the cellular events within the adult human atria was a stable TL during 6 decades of life. The present data suggested that this stability, in turn, could provide a framework for internally referencing leukocyte TL, so that that the interindividual variability in TL due to inheritance is partially accounted for.
Recent data from Sabharwal et al. (15) Post-operative complications 15 (12) 11 (11) 4 (15) In-hospital mortality 3 (2) 1 (1) 2 (8) Cardiac arrest/life-threatening arrhythmia 4 (3) 2 (2) 2 (8) Intraaortic balloon pump use 1 (1) 1 ( Values are n (%), unless otherwise noted.
ICU ¼ intensive care unit. 
CONCLUSIONS
We found that relating leukocyte TL to cardiac atrial TL constituted a biologically rational strategy for gauging leukocyte telomere shortening. The findings raise the possibility of using a personalized index of telomere dynamics to inform care.
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